Page 16 - Biomedicine

3.Taiwan Industry Innovation Platform Program
The MOEA Industrial Development Bureau and the Ministry of Science and
Technology are jointly implementing the "Taiwan Industry Innovation Platform
Program" to guide industries to develop towards greater value, and to encourage
companies to enter high-end product application markets to increase industry's
overall added value. For companies owning R&D teams in Taiwan, the program
provides 40-50% of the funding required for theme-based R&D projects, and up to
40% of funding for R&D projects proposed by the companies themselves.

3 Measures taken by local governments

To support the development of venture companies, local governments have also
provided resources such as "investing in or sponsoring" review or contest mechanisms,
setting up "incubation or acceleration devices," training talent on occupational
knowledge, and providing free or economic office space, among others, to help
venture companies achieve strong growth; this also applies to the biopharmaceutical
industry.

Successful Examples of

Foreign Companies

1 Clinical trials

Many international giant pharmaceutical companies, such as GSK and Novartis,
have come to Taiwan to set up clinical trial research centers for investigational new
drugs. They have been attracted here by Taiwan's outstanding medical environment,
quality healthcare professionals, and medical technology and equipment comparable

14